Clinical trial

Appetite Increase in Schizophrenia Patients Treated With Atypical Antipsychotics

NCT00290121 · Université de Montréal, Other · Completed

Key facts

NCT number NCT00290121
Title Appetite Increase in Schizophrenia Patients Treated With Atypical Antipsychotics
Official title Cerebral Mechanism Involved in Appetite Increase in Schizophrenia Patients Treated With Atypical Antipsychotics (IIT)
Lead sponsor Université de Montréal, Other
Collaborators Centre de Recherche de l'Institut Universitaire en santé Mentale de Montréal Centre de Recherche de l'Institut Universitaire de Geriatrie de Montreal Centre Integre Universitaire de Sante et Services…
Status Completed
Phase Phase 4
Study type Interventional
Conditions Schizophrenia
Intervention type Drug
Interventions Olanzapine
Enrollment 25
Start date Sep 1, 2006
Primary completion Jun 1, 2008
Completion Jun 1, 2008
First posted Feb 10, 2006
Last update posted Mar 14, 2013
Countries Canada

At a glance

  • 1–9 Study sites
  • No Results posted
  • None Linked FDA submissions

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About ClinicalTrials.gov studies

ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.

Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date:

Browse all ClinicalTrials.gov studies